| dc.contributor.author | IRVINE, ALAN | en |
| dc.date.accessioned | 2016-02-25T14:00:51Z | |
| dc.date.available | 2016-02-25T14:00:51Z | |
| dc.date.issued | 2014 | en |
| dc.date.submitted | 2014 | en |
| dc.identifier.citation | Irvine AD, Commentary: Methotrexate and ciclosporin in the treatment of severe eczema in children., The British journal of dermatology, 170, 3, 2014, 499-500 | en |
| dc.identifier.issn | 0007-0963 | en |
| dc.identifier.other | Y | en |
| dc.description | PUBLISHED | en |
| dc.format.extent | 499-500 | en |
| dc.relation.ispartofseries | The British journal of dermatology | en |
| dc.relation.ispartofseries | 170 | en |
| dc.relation.ispartofseries | 3 | en |
| dc.rights | Y | en |
| dc.subject | Commentary | en |
| dc.title | Commentary: Methotrexate and ciclosporin in the treatment of severe eczema in children. | en |
| dc.type | Journal Article | en |
| dc.type.supercollection | scholarly_publications | en |
| dc.type.supercollection | refereed_publications | en |
| dc.identifier.peoplefinderurl | http://people.tcd.ie/irvinea | en |
| dc.identifier.rssinternalid | 112979 | en |
| dc.identifier.doi | http://dx.doi.org/10.1111/bjd.12821 | en |
| dc.rights.ecaccessrights | openAccess | |
| dc.identifier.orcid_id | 0000-0002-9048-2044 | en |
| dc.identifier.uri | http://hdl.handle.net/2262/75986 | |
